Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

91.7%

+5.2% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
1(25.0%)
Phase 2
1(25.0%)
Phase 1
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(1)
Phase 2(1)
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT06585319Phase 2Completed

Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19

Role: lead

NCT04406246Phase 4Completed

Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide

Role: lead

NCT03964987Completed

Pancreatic Duodenal Homeobox Factor-1 (PDX-1) and Neurogenin-3 (NGN-3) in Gestational Diabetes

Role: lead

NCT03761966Completed

Cytokines Profile at the Beginning of Pregnancy

Role: lead

NCT03612908Completed

TSHβX1 and D2 THR92ALA in Pregnancy

Role: lead

NCT03100383Completed

Influence of Medical Nutrition Therapy and Eating Behavior on Gestational Weight Gain

Role: lead

NCT00985010Terminated

Manganese in Women With Encephalopathy

Role: lead

NCT02395835Completed

Methylation of the PPARg Promoter Region in Pregnancy

Role: lead

NCT01924117Not ApplicableCompleted

Genotypification and Predisposing Factors in Human Papilloma Virus Infection

Role: lead

NCT01667939Phase 1Completed

A Supervised Nutritional Program in Pregnancies and NF-κB Expression in Placenta

Role: lead

NCT01649167Completed

Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia

Role: lead

NCT01643148Completed

The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer

Role: lead

All 12 trials loaded